- Home
- NYMT vs PRME Comparison
NYMT vs PRME Comparison
Compare NYMT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- PRME
- Stock Information
- Founded
- NYMT 2003
- PRME 2019
- Country
- NYMT United States
- PRME United States
- Employees
- NYMT N/A
- PRME N/A
- Industry
- NYMT Real Estate Investment Trusts
- PRME Medicinal Chemicals and Botanical Products
- Sector
- NYMT Real Estate
- PRME Health Care
- Exchange
- NYMT Nasdaq
- PRME Nasdaq
- Market Cap
- NYMT 615.9M
- PRME 624.0M
- IPO Year
- NYMT 2004
- PRME 2022
- Fundamental
- Price
- NYMT $7.14
- PRME $3.55
- Analyst Decision
- NYMT Strong Buy
- PRME Buy
- Analyst Count
- NYMT 4
- PRME 6
- Target Price
- NYMT $7.81
- PRME $8.88
- AVG Volume (30 Days)
- NYMT 712.6K
- PRME 4.0M
- Earning Date
- NYMT 07-30-2025
- PRME 08-07-2025
- Dividend Yield
- NYMT 11.59%
- PRME N/A
- EPS Growth
- NYMT N/A
- PRME N/A
- EPS
- NYMT 0.19
- PRME N/A
- Revenue
- NYMT $205,403,000.00
- PRME $4,961,000.00
- Revenue This Year
- NYMT $6.23
- PRME $126.92
- Revenue Next Year
- NYMT $12.09
- PRME $87.32
- P/E Ratio
- NYMT $35.93
- PRME N/A
- Revenue Growth
- NYMT 23.27
- PRME 739.42
- 52 Week Low
- NYMT $5.02
- PRME $1.11
- 52 Week High
- NYMT $7.27
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- NYMT 61.92
- PRME 48.57
- Support Level
- NYMT $6.90
- PRME $3.09
- Resistance Level
- NYMT $7.11
- PRME $3.88
- Average True Range (ATR)
- NYMT 0.15
- PRME 0.31
- MACD
- NYMT 0.04
- PRME -0.09
- Stochastic Oscillator
- NYMT 90.41
- PRME 32.96
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.